Literature DB >> 24234009

Molecular carrier testing for the fragile X syndrome: Issues for genetic counselors.

J L Berliner1, F N Shapiro, S L Nolin, G E Houck, X H Ding, C Dobkin, S S Brooks, W T Brown.   

Abstract

Molecular analysis of the fragile X (FMR-1) gene identifies female fragile X carriers, but appropriate genetic counseling can only be provided if the limitations of the testing methods are understood. Molecular analysis of this gene is achieved with both the polymerase chain reaction (PCR) and Southern blot techniques. PCR is faster and can determine the actual number of CGG repeats, which modifies genetic counseling substantially. However, for a sizeable percentage of women, PCR alone is not conclusive, and Southern analysis is necessary to complete the study. While this procedure takes longer, it is usually conclusive. Women who present for genetic counseling and carrier testing in the second trimester of pregnancy need this information quickly, and for them the turn-around time is paramount. It is critical that genetic counselors understand these methods so that they can educate their clients and facilitate appropriate follow-up.

Entities:  

Year:  1994        PMID: 24234009     DOI: 10.1007/BF01412229

Source DB:  PubMed          Journal:  J Genet Couns        ISSN: 1059-7700            Impact factor:   2.537


  18 in total

1.  Frequent small amplifications in the FMR-1 gene in fra(X) families: limits to the diagnosis of 'premutations'.

Authors:  J N Macpherson; D L Nelson; P A Jacobs
Journal:  J Med Genet       Date:  1992-11       Impact factor: 6.318

2.  Prenatally detected fragile X females: long-term follow-up studies show high risk of mental impairment.

Authors:  W T Brown; E C Jenkins; P Goonewardena; C Miezejeski; J Atkin; D Devys
Journal:  Am J Med Genet       Date:  1992 Apr 15-May 1

3.  Prenatal diagnosis of fragile X syndrome by direct detection of the unstable DNA sequence.

Authors:  G R Sutherland; A Gedeon; L Kornman; A Donnelly; R W Byard; J C Mulley; E Kremer; M Lynch; M Pritchard; S Yu
Journal:  N Engl J Med       Date:  1991-12-12       Impact factor: 91.245

4.  Genetic mapping of new DNA probes at Xq27 defines a strategy for DNA studies in the fragile X syndrome.

Authors:  G K Suthers; J C Mulley; M A Voelckel; N Dahl; M L Väisänen; P Steinbach; I A Glass; C E Schwartz; B A van Oost; S N Thibodeau
Journal:  Am J Hum Genet       Date:  1991-03       Impact factor: 11.025

5.  The marker (X) syndrome: a cytogenetic and genetic analysis.

Authors:  S L Sherman; N E Morton; P A Jacobs; G Turner
Journal:  Ann Hum Genet       Date:  1984-01       Impact factor: 1.670

6.  Variation of the CGG repeat at the fragile X site results in genetic instability: resolution of the Sherman paradox.

Authors:  Y H Fu; D P Kuhl; A Pizzuti; M Pieretti; J S Sutcliffe; S Richards; A J Verkerk; J J Holden; R G Fenwick; S T Warren
Journal:  Cell       Date:  1991-12-20       Impact factor: 41.582

7.  Further segregation analysis of the fragile X syndrome with special reference to transmitting males.

Authors:  S L Sherman; P A Jacobs; N E Morton; U Froster-Iskenius; P N Howard-Peebles; K B Nielsen; M W Partington; G R Sutherland; G Turner; M Watson
Journal:  Hum Genet       Date:  1985       Impact factor: 4.132

8.  Incomplete X chromosome dosage compensation in chorionic villi of human placenta.

Authors:  B R Migeon; S F Wolf; J Axelman; D C Kaslow; M Schmidt
Journal:  Proc Natl Acad Sci U S A       Date:  1985-05       Impact factor: 11.205

9.  Absence of expression of the FMR-1 gene in fragile X syndrome.

Authors:  M Pieretti; F P Zhang; Y H Fu; S T Warren; B A Oostra; C T Caskey; D L Nelson
Journal:  Cell       Date:  1991-08-23       Impact factor: 41.582

Review 10.  Diagnostic molecular genetics of the fragile X.

Authors:  G R Sutherland; J C Mulley
Journal:  Clin Genet       Date:  1990-01       Impact factor: 4.438

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.